Jaguar Health, Inc. (JAGX)
NASDAQ: JAGX · Real-Time Price · USD
3.050
+0.350 (12.96%)
At close: Jun 24, 2025, 4:00 PM
2.900
-0.150 (-4.92%)
After-hours: Jun 24, 2025, 7:57 PM EDT

Jaguar Health Statistics

Total Valuation

Jaguar Health has a market cap or net worth of $4.04 million. The enterprise value is $36.41 million.

Market Cap 4.04M
Enterprise Value 36.41M

Important Dates

The next estimated earnings date is Tuesday, August 12, 2025, before market open.

Earnings Date Aug 12, 2025
Ex-Dividend Date n/a

Share Statistics

Jaguar Health has 1.32 million shares outstanding. The number of shares has increased by 934.82% in one year.

Current Share Class 1.32M
Shares Outstanding 1.32M
Shares Change (YoY) +934.82%
Shares Change (QoQ) +31.57%
Owned by Insiders (%) 8.07%
Owned by Institutions (%) 5.28%
Float 1.08M

Valuation Ratios

PE Ratio n/a
Forward PE n/a
PS Ratio 0.10
Forward PS 0.25
PB Ratio 1.02
P/TBV Ratio n/a
P/FCF Ratio n/a
P/OCF Ratio n/a
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

EV / Earnings n/a
EV / Sales 3.15
EV / EBITDA n/a
EV / EBIT n/a
EV / FCF n/a

Financial Position

The company has a current ratio of 1.08, with a Debt / Equity ratio of 11.56.

Current Ratio 1.08
Quick Ratio 0.25
Debt / Equity 11.56
Debt / EBITDA n/a
Debt / FCF n/a
Interest Coverage n/a

Financial Efficiency

Return on equity (ROE) is -459.52% and return on invested capital (ROIC) is -44.79%.

Return on Equity (ROE) -459.52%
Return on Assets (ROA) -37.48%
Return on Invested Capital (ROIC) -44.79%
Return on Capital Employed (ROCE) -137.78%
Revenue Per Employee $235,755
Profits Per Employee -$810,816
Employee Count 49
Asset Turnover 0.22
Inventory Turnover 0.21

Taxes

Income Tax n/a
Effective Tax Rate n/a

Stock Price Statistics

The stock price has decreased by -96.89% in the last 52 weeks. The beta is 0.70, so Jaguar Health's price volatility has been lower than the market average.

Beta (5Y) 0.70
52-Week Price Change -96.89%
50-Day Moving Average 6.13
200-Day Moving Average 18.18
Relative Strength Index (RSI) 31.63
Average Volume (20 Days) 86,781

Short Selling Information

The latest short interest is 28,785, so 2.17% of the outstanding shares have been sold short.

Short Interest 28,785
Short Previous Month 32,263
Short % of Shares Out 2.17%
Short % of Float 2.65%
Short Ratio (days to cover) 0.25

Income Statement

In the last 12 months, Jaguar Health had revenue of $11.55 million and -$39.73 million in losses. Loss per share was -$93.54.

Revenue 11.55M
Gross Profit 9.51M
Operating Income -32.04M
Pretax Income -38.32M
Net Income -39.73M
EBITDA -30.16M
EBIT -32.04M
Loss Per Share -$93.54
Full Income Statement

Balance Sheet

The company has $5.69 million in cash and $38.34 million in debt, giving a net cash position of -$32.65 million or -$24.65 per share.

Cash & Cash Equivalents 5.69M
Total Debt 38.34M
Net Cash -32.65M
Net Cash Per Share -$24.65
Equity (Book Value) 3.32M
Book Value Per Share 2.64
Working Capital 2.23M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$29.65 million and capital expenditures -$16,000, giving a free cash flow of -$29.67 million.

Operating Cash Flow -29.65M
Capital Expenditures -16,000
Free Cash Flow -29.67M
FCF Per Share -$22.40
Full Cash Flow Statement

Margins

Gross Margin 82.34%
Operating Margin -277.33%
Pretax Margin -350.41%
Profit Margin n/a
EBITDA Margin -261.07%
EBIT Margin -277.33%
FCF Margin n/a

Dividends & Yields

Jaguar Health does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio n/a
Buyback Yield -934.82%
Shareholder Yield -934.82%
Earnings Yield -1,056.86%
FCF Yield -789.23%

Analyst Forecast

The average price target for Jaguar Health is $60.00, which is 1,867.21% higher than the current price. The consensus rating is "Strong Buy".

Price Target $60.00
Price Target Difference 1,867.21%
Analyst Consensus Strong Buy
Analyst Count 1
Revenue Growth Forecast (5Y) n/a
EPS Growth Forecast (5Y) n/a
Stock Forecasts

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value n/a
Lynch Upside n/a
Graham Number n/a
Graham Upside n/a

Stock Splits

The last stock split was on March 24, 2025. It was a reverse split with a ratio of 0.04:1.

Last Split Date Mar 24, 2025
Split Type Reverse
Split Ratio 0.04:1

Scores

Jaguar Health has an Altman Z-Score of -11.26 and a Piotroski F-Score of 4. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score -11.26
Piotroski F-Score 4